mram_Current_Folio_10Q

Table of Contents

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q


(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2018

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to             

 

Commission File Number 001-37900


Everspin Technologies, Inc.

(Exact name of Registrant as specified in its Charter)


 

Delaware

    

26-2640654

(State or other jurisdiction

of incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

5670 W. Chandler Boulevard, Suite 100

Chandler, Arizona 85226

(Address of principal executive offices including zip code)

 

Registrant’s telephone number, including area code: (480) 347-1111


Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    YES      NO  

 

Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files).    YES      NO  

 

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer

 

Accelerated filer

Non-accelerated filer

  (Do not check if a small reporting company)

 

Small reporting company

 

 

 

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    YES      NO  

 

The number of shares of Registrant’s Common Stock outstanding as of May 2, 2018 was 16,673,683.

 

 


 

Table of Contents

Table of Contents

 

 

 

 

 

 

    

 

Page

 

 

PART I—FINANCIAL INFORMATION

 

Item 1. 

 

Financial Statements 

3

 

 

Condensed Balance Sheets as of March 31, 2018 (unaudited) and December 31, 2017

3

 

 

Condensed Statements of Operations and Comprehensive Loss for the three months ended March 31, 2018 and 2017 (unaudited)

4

 

 

Condensed Statements of Cash Flows for the three months ended March 31, 2018 and 2017 (unaudited)

5

 

 

Notes to Condensed Financial Statements (unaudited)

6

Item 2. 

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

21

Item 3. 

 

Quantitative and Qualitative Disclosures About Market Risk

31

Item 4. 

 

Controls and Procedures

31

 

 

 

 

 

 

PART II—OTHER INFORMATION

 

Item 1. 

 

Legal Proceedings

32

Item 1A. 

 

Risk Factors

32

Item 2. 

 

Unregistered Sales of Equity Securities and Use of Proceeds

52

Item 3. 

 

Defaults Upon Senior Securities

53

Item 4. 

 

Mine Safety Disclosures

53

Item 5. 

 

Other Information

53

Item 6. 

 

Exhibits

53

EXHIBIT INDEX 

54

SIGNATURES 

55

 

In this Quarterly Report on Form 10-Q, “we,” “our,” “us,” “Everspin Technologies,” and “the Company” refer to Everspin Technologies, Inc. The Everspin logo and other trade names, trademarks or service marks of Everspin Technologies are the property of Everspin Technologies, Inc. This report contains references to our trademarks and to trademarks belonging to other entities. Trade names, trademarks and service marks of other companies appearing in this report are the property of their respective holders. We do not intend our use or display of other companies’ trade names or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other companies.

2


 

Table of Contents

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

 

EVERSPIN TECHNOLOGIES, INC.

Condensed Balance Sheets

(In thousands, except share and per share amounts)

 

 

 

 

 

 

 

 

 

 

March 31, 

 

December 31, 

 

 

2018

 

2017

 

 

(Unaudited)

 

(See Note 2)

Assets

 

 

  

 

 

  

Current assets:

 

 

  

 

 

  

Cash and cash equivalents

 

$

33,883

 

$

12,950

Accounts receivable, net

 

 

8,904

 

 

3,429

Amounts due from related parties

 

 

382

 

 

612

Inventory

 

 

8,903

 

 

9,837

Prepaid expenses and other current assets

 

 

1,207

 

 

590

Total current assets

 

 

53,279

 

 

27,418

Property and equipment, net

 

 

3,775

 

 

3,946

Other assets

 

 

93

 

 

73

Total assets

 

$

57,147

 

$

31,437

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

  

 

 

  

Current liabilities:

 

 

  

 

 

  

Accounts payable

 

$

2,337

 

$

2,720

Accrued liabilities

 

 

2,127

 

 

2,254

Amounts due to related parties

 

 

3,734

 

 

1,694

Deferred income on shipments to distributors

 

 

 —

 

 

1,720

Current portion of long-term debt

 

 

5,490

 

 

3,987

Total current liabilities

 

 

13,688

 

 

12,375

Long-term debt, net of current portion

 

 

6,772

 

 

8,178

Total liabilities

 

 

20,460

 

 

20,553

Commitments and contingencies

 

 

  

 

 

  

Stockholders’ equity:

 

 

  

 

 

  

Preferred stock, $0.0001 par value per share; 5,000,000 shares authorized; no shares issued and outstanding as of March 31, 2018 and December 31, 2017

 

 

 —

 

 

 —

Common stock, $0.0001 par value per share; 100,000,000 shares authorized; 16,648,271 and 12,817,201 shares issued and outstanding as of March 31, 2018 and December 31, 2017

 

 

 2

 

 

 1

Additional paid-in capital

 

 

154,201

 

 

128,422

Accumulated deficit

 

 

(117,516)

 

 

(117,539)

Total stockholders’ equity

 

 

36,687

 

 

10,884

Total liabilities and stockholders’ equity

 

$

57,147

 

$

31,437

 

The accompanying notes are an integral part of these condensed financial statements.

3


 

Table of Contents

EVERSPIN TECHNOLOGIES, INC.

Condensed Statements of Operations and Comprehensive Loss

(In thousands, except share and per share amounts)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

March 31, 

 

 

    

2018

    

2017

    

Product sales

 

$

9,264

 

$

6,648

 

Product sales - related party

 

 

101

 

 

 —

 

Licensing, royalty, and other revenue

 

 

5,107

 

 

91

 

Licensing, royalty, and other revenue - related party

 

 

381

 

 

1,141

 

Total revenue

 

 

14,853

 

 

7,880

 

Cost of sales

 

 

4,898

 

 

3,663

 

Gross profit

 

 

9,955

 

 

4,217

 

Operating expenses:

 

 

  

 

 

  

 

Research and development

 

 

6,480

 

 

6,389

 

General and administrative

 

 

3,219

 

 

2,845

 

Sales and marketing

 

 

1,366

 

 

858

 

Total operating expenses

 

 

11,065

 

 

10,092

 

Loss from operations

 

 

(1,110)

 

 

(5,875)

 

Interest expense

 

 

(211)

 

 

(230)

 

Other income, net

 

 

44

 

 

19

 

Net loss and comprehensive loss

 

$

(1,277)

 

$

(6,086)

 

Net loss per common share, basic and diluted

 

$

(0.09)

 

$

(0.49)

 

Weighted-average shares used to compute net loss per common share, basic and diluted

 

 

14,789,036

 

 

12,299,981

 

 

The accompanying notes are an integral part of these condensed financial statements.

4


 

Table of Contents

EVERSPIN TECHNOLOGIES, INC.

Condensed Statement of Cash Flows

(In thousands)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

March 31, 

 

 

    

2018

    

2017

 

Cash flows from operating activities

 

 

  

 

 

  

 

Net loss

 

$

(1,277)

 

$

(6,086)

 

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

  

 

 

  

 

Depreciation and amortization

 

 

373

 

 

232

 

Stock-based compensation

 

 

625

 

 

431

 

Non-cash interest expense

 

 

100

 

 

59

 

Compensation expense related to vesting of common stock to GLOBALFOUNDRIES

 

 

237

 

 

255

 

Changes in operating assets and liabilities:

 

 

 

 

 

  

 

Accounts receivable

 

 

(5,810)

 

 

513

 

Amounts due from related parties

 

 

230

 

 

(37)

 

Inventory

 

 

888

 

 

(755)

 

Prepaid expenses and other current assets

 

 

(617)

 

 

211

 

Other assets

 

 

(20)

 

 

(11)

 

Accounts payable

 

 

(353)

 

 

695

 

Accrued liabilities

 

 

(127)

 

 

93

 

Amounts due to related parties

 

 

2,052

 

 

717

 

Deferred income on shipments to distributors

 

 

(39)

 

 

(357)

 

Net cash used in operating activities

 

 

(3,738)

 

 

(4,040)

 

Cash flows from investing activities

 

 

  

 

 

  

 

Purchases of property and equipment

 

 

(244)

 

 

(470)

 

Net cash used in investing activities

 

 

(244)

 

 

(470)

 

Cash flows from financing activities

 

 

  

 

 

  

 

Proceeds from the issuance of common stock, net of offering costs

 

 

24,609

 

 

 —

 

Payments on debt

 

 

 —

 

 

(727)

 

Payments on capital lease obligation

 

 

(3)

 

 

(7)

 

Proceeds from exercise of stock options and purchase of shares in employee stock purchase plan

 

 

309

 

 

 9

 

Net cash provided by (used in) financing activities

 

 

24,915

 

 

(725)

 

Net increase (decrease) in cash and cash equivalents

 

 

20,933

 

 

(5,235)

 

Cash and cash equivalents at beginning of period

 

 

12,950

 

 

29,727

 

Cash and cash equivalents at end of period

 

$

33,883

 

$

24,492

 

Supplementary cash flow information:

 

 

  

 

 

  

 

Interest paid

 

$

111

 

$

171

 

Non-cash investing and financing activities:

 

 

  

 

 

  

 

Purchase of property and equipment in accounts payable and amounts due to related parties

 

$

73

 

$

965

 

 

The accompanying notes are an integral part of these condensed financial statements.

5


 

Table of Contents

EVERSPIN TECHNOLOGIES, INC.

 

Notes to Unaudited Condensed Financial Statements

 

1. Organization and Nature of Business

 

Everspin Technologies, Inc. (the Company) was incorporated in Delaware on May 16, 2008. The Company’s magnetoresistive (MRAM) solutions offer the persistence of non-volatile memory with the speed and endurance of random access memory (RAM) and enable the protection of mission critical data particularly in the event of power interruption or failure. The Company’s MRAM solutions allow its customers in the industrial, automotive and transportation, and enterprise storage markets to design high performance, power efficient and reliable systems without the need for bulky batteries or capacitors.

 

Ability to continue as a going concern 

 

The Company believes that its existing cash and cash equivalents as of March 31, 2018,  coupled with its anticipated growth and sales levels will be sufficient to meet its anticipated cash requirements for at least the next twelve months from the financial statement issuance date of May 9, 2018. The Company’s future capital requirements will depend on many factors, including its growth rate, the timing and extent of its spending to support research and development activities, the timing and cost of establishing additional sales and marketing capabilities, and the introduction of new products. The Company may be required at some point in the future to seek additional equity or debt financing, to sustain operations beyond that point, and such additional financing may not be available on acceptable terms or at all. If the Company is unable to raise additional capital or generate sufficient cash from operations to adequately fund its operations, it will need to curtail planned activities to reduce costs. Doing so will likely harm its ability to execute on its business plan.

 

2. Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (GAAP) and applicable rules and regulations of the Securities and Exchange Commission (SEC) regarding interim financial reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted, and accordingly the balance sheet as of December 31, 2017 has been derived from the audited financial statements at that date but does not include all of the information required by GAAP for complete financial statements. These unaudited interim condensed financial statements have been prepared on the same basis as the Company’s annual financial statements and, in the opinion of management, reflect all adjustments (consisting only of normal recurring adjustments) that are necessary for a fair statement of the Company’s financial information. The results of operations for the three months ended March 31, 2018 are not necessarily indicative of the results to be expected for the year ending December 31, 2018 or for any other interim period or for any other future year.

 

The accompanying condensed financial statements and related financial information should be read in conjunction with the audited financial statements and the related notes thereto for the year ended December 31, 2017, included in the Company’s Annual Report on Form 10-K filed with the SEC.

 

Use of Estimates

 

The preparation of the condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, fair value of assets and liabilities, inventory, income taxes, and stock-based compensation. Actual results could differ from those estimates and assumptions.

 

6


 

Table of Contents

Accounts receivable, net

 

Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company generally does not require collateral or other security in support of accounts receivable. Allowances are provided for individual accounts receivable when the Company becomes aware of a customer’s inability to meet its financial obligations, such as in the case of bankruptcy, deterioration in the customer’s operating results or change in financial position. If circumstances related to customers change, estimates of the recoverability of receivables would be further adjusted. The Company also considers a number of factors in evaluating the sufficiency of its allowance for doubtful accounts, including the length of time receivables are past due, significant one-time events, creditworthiness of customers and historical experience. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. At March 31, 2018 and December 31, 2017, there was no allowance for doubtful accounts.

 

The Company also establishes an allowance for product returns. The Company analyzes historical returns, current economic trends and changes in customer demand and acceptance of products when evaluating the adequacy of sales returns. As the returns are processed as credits on future purchases, the allowance is recorded against the balance of trade accounts receivable. In addition, the Company establishes an allowance for estimated price concessions related to its distributer agreements. The Company estimates credits to distributors based on the historical rate of credits provided to distributors relative to sales or, for some customers the credit is based on a previously negotiated fixed rate. At March 31, 2018, the allowance for product returns and the allowance for price concessions were $173,000 and $399,000, respectively. At December 31, 2017, the allowance for product returns and the allowance for price concessions were $147,000 and $0, respectively.

 

Accounts receivable, net consisted of the following (in thousands):

 

 

 

 

 

 

 

 

 

 

March 31, 

 

December 31, 

 

 

2018

 

2017

Trade accounts receivable

 

$

9,440

 

$

3,576

Allowance for accounts receivable

 

 

(572)

 

 

(147)

Unbilled accounts receivable

 

 

36

 

 

 —

Accounts receivable, net

 

$

8,904

 

$

3,429

 

Concentration of Credit Risk

 

Financial instruments that potentially expose the Company to a concentration of credit risk consist principally of cash and cash equivalents that are held by a financial institution in the United States and accounts receivable. Amounts on deposit with a financial institution may at times exceed federally insured limits. The Company maintains its cash accounts with high credit quality financial institutions and, accordingly, minimal credit risk exists with respect to the financial institutions.

 

Significant customers are those which represent more than 10% of the Company’s total revenue or net accounts receivable balance at each respective balance sheet date. For the purposes of this disclosure, the Company defines “customer” as the entity that is purchasing the products or licenses directly from the Company, which includes the distributors of the Company’s products in addition to end customers that the Company sells to directly. For each significant customer, revenue as a percentage of total revenue and accounts receivable as a percentage of total accounts receivable, net are as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

Accounts Receivable, net

 

 

 

 

Three Months Ended

 

As of

 

As of

 

 

 

 

March 31, 

 

March 31, 

 

December 31, 

 

 

Customers

    

2018

    

2017

    

2018

    

2017

 

 

Customer A

 

34

%

*

 

54

%

*

 

 

Customer B

 

13

 

10

%  

*

    

*

 

 

Customer C

 

*

 

18

%  

*

    

*

 

 

Customer D

 

*

 

*

 

*

    

15

%

 

Customer E

 

*

 

13

%  

*

    

10

%

 


*Less than 10%

7


 

Table of Contents

 

Fair Value of Financial Instruments

 

The Company discloses and recognizes the fair value of its assets and liabilities using a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The hierarchy gives the highest priority to valuations based upon unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to valuations based upon unobservable inputs that are significant to the valuation (Level 3 measurements). The guidance establishes three levels of the fair value hierarchy as follows:

 

Level 1—Inputs are unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date.

 

Level 2—Inputs (other than quoted market prices included in Level 1) are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life.

 

Level 3—Inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.

 

The carrying value of accounts receivable, accounts payable, and other accruals readily convertible into cash approximate fair value because of the short-term nature of the instruments. As of March 31, 2018, based on Level 2 inputs and the borrowing rates available to the Company for loans with similar terms and consideration of the Company’s credit risk, the carrying value of the Company’s variable interest rate debt, excluding unamortized debt issuance costs, approximates fair value. The Company’s financial instruments consist of Level 1 assets. Where quoted prices are available in an active market, securities are classified as Level 1. Level 1 assets consist of highly liquid money market funds that are included in cash equivalents.

 

The following table sets forth the fair value of the Company’s financial assets measured at fair value on a recurring basis based on the three-tier fair value hierarchy (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31, 2018

 

    

Level 1

    

Level 2

    

Level 3

    

 

Total

Assets:

 

 

 

  

 

 

  

 

 

  

 

 

Money market funds

 

$

34,408

  

$

 —

  

$

 —

  

$

34,408

Total assets measured at fair value

 

$

34,408

  

$

 —

  

$

 —

  

$

34,408

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2017

 

    

Level 1

    

Level 2

    

Level 3

    

 

Total

Assets:

 

 

 

  

 

 

  

 

 

  

 

 

Money market funds

 

$

13,369

  

$

  

$

  

$

13,369

Total assets measured at fair value

 

$

13,369

  

$

 —

  

$

 —

  

$

13,369

 

Revenue Recognition

 

The Company recognizes revenue when a customer obtains control of the promised products or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those products or services. Revenue is recognized net of allowances for returns and price concessions, and any taxes collected from customers, which are subsequently remitted to governmental authorities.

 

Nature of Products and Services

 

The Company’s revenue is derived from the sale of MRAM-based products in discrete unit form, licenses of and royalties on its MRAM and magnetic sensor technology, the sale of backend foundry services and design services to third parties. Sales of products in discrete unit form are recognized at a point in time, revenue related to licensing agreements is recognized when the Company has delivered rights to the technology, revenue related to royalty

8


 

Table of Contents

agreements is recognized in the period in which sales generated from products sold using the Company’s technology occurs, and sales of backend foundry services and design services to third parties are recognized over time.

 

Product Revenue

 

For products sold in their discrete form, the Company either sells its products directly to original equipment manufacturers (OEMs), original design manufacturers (ODMs) and contract manufacturers (CMs), or through a network of distributors, who in turn sell to those customers. For sales directly to OEMs, ODMs and CMs, revenue is recognized when the OEM, ODM or CM obtains control of the product, which occurs at a point in time, generally upon shipment to the customer.

 

The Company sells the majority of its products to its distributors at a uniform list price. However, distributors may resell the Company’s products to end customers at a very broad range of individually negotiated price points. Distributors are provided with price concessions subsequent to the delivery of product to them and such amounts are dependent on the end customer and product sales price. The price concessions are based on a variety of factors, including customer, product, quantity, geography and competitive differentiation. Price protection rights grant distributors the right to a credit in the event of declines in the price of the Company’s products. Under these circumstances, the Company remits back to the distributor a portion of their original purchase price after the resale transaction is completed in the form of a credit against the distributors’ outstanding accounts receivable balance. The credits are on a per unit basis and are not given to the distributor until the distributor provides information regarding the sale to their end customer. The Company estimates these credits and records such estimates in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of an allowance for price concessions due to distributors. The Company estimates credits to distributors based on the historical rate of credits provided to distributors relative to sales or, for some customers the credit is based on a previously negotiated fixed rate. Revenue on shipments to distributors is recorded when control of the products has been transferred to the distributor.

 

The Company estimates the amount of its product sales that may be returned by its customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. The Company estimates its product return liability by analyzing its historical returns, current economic trends and changes in customer demand and acceptance of products. The Company has received insignificant returns to date and believes that returns of its products will continue to be minimal.  As such, the Company does not record any reserve for returns but will continue to evaluate the need for a reserve each reporting period.

 

At the time of shipment to distributors, the Company records a trade receivable for the selling price as there is a legally enforceable obligation of the distributor to pay for the product delivered, an allowance is recorded for the estimated discount that will be provided to the distributor, and the net of these amounts is recorded as revenue on the statement of operations.

 

License Revenue

 

For licenses of technology, recognition of revenue is dependent upon whether the Company has delivered rights to the technology, and whether there are future performance obligations under the contract. In some instances, the license agreements call for future events or activities to occur in order for milestones amounts to become due from the customer. The terms of such agreements include payment to the Company of one or more of the following: non-refundable upfront fees; and royalties on net sales of licensed products. Historically, these license agreements have not included other future performance obligations for the Company once the license has been transferred to the customer. 

 

The transaction price in each agreement is allocated to the identified performance obligations based on the standalone selling price (SSP) of each distinct performance obligation. Judgment is required to determine SSP. In instances where SSP is not directly observable, such as when a license or service is not sold separately, SSP is determined using information that may include market conditions and other observable inputs. 

 

Revenue from non-refundable up-front payments is recognized when the license is transferred to the customer and the Company has no other performance obligations.

 

9


 

Table of Contents

Royalties

 

Revenue from sales-based royalties from licenses of the Company’s technology are recognized at the later of when (1) the sale occurs or (2) the performance obligation to which some or all of the sales-based royalty has been allocated is satisfied (in whole or in part).

 

Other Revenue

 

For certain revenue streams, the Company recognizes revenue based on the pattern of transfer of the services. The Company uses the input method of measuring costs incurred to date compared to total estimated costs to be incurred under the contract as this method most faithfully depicts its performance.  The Company will record an unbilled receivable (within accounts receivable, net) for the portion of the work that has been completed but not invoiced at the end of each reporting period. 

 

Revenue from milestone payments must be estimated using either the expected value method or the most likely amount method. At the inception of each agreement that includes milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price by using the most likely amount method. If it is probable that a significant reversal of cumulative revenue would not occur, the associated milestone value is included in the transaction price. At the end of each subsequent reporting period, the Company re-evaluates the probability or achievement of each such milestone and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment.

 

Net Loss per Common Share

 

Basic net loss per common share is calculated by dividing the net loss by the weighted-average number of shares of common stock outstanding for the period, less shares subject to repurchase, without consideration of potentially dilutive securities. Diluted net loss per common share is the same as basic net loss per common share since the effect of potentially dilutive securities is anti-dilutive.

 

Prior Period Reclassifications

 

Certain amounts in the prior period have been reclassified to conform with current period presentation. There was no impact on total revenue or net loss for the prior period.

 

Recently Adopted Pronouncements

 

ASU No. 2014-09, Revenue from Contracts with Customers

 

In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers (Topic 606). Areas of revenue recognition that will be affected include, but are not limited to, transfer of control, variable consideration, allocation of transfer pricing, licenses, time value of money, contract costs and disclosures. The new standard permits adoption either by using (i) a full retrospective approach for all periods presented in the period of adoption or (ii) a modified retrospective approach with the cumulative effect of initially applying the new standard recognized at the date of initial application and providing certain additional disclosures. The new standard is effective for annual reporting periods beginning after December 15, 2017. The Company adopted this standard on January 1, 2018 using the modified retrospective method. The Company recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of its accumulated deficit. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods.

 

As a result of the adoption of the new standard, the Company changed its accounting policy for revenue recognition and the details of the significant changes and quantitative impact of the changes are disclosed below.

 

Distributor sales - Some of the Company's contracts with distributors provide the distributor with certain concessions and price protection credits. Under Topic 605, Revenue, these concessions and price protection credits were not fixed or determinable and, as a result, the associated revenue was deferred until delivery of the product to

10


 

Table of Contents

the end customer. At the time of shipment to distributors, the Company recorded a trade receivable for the selling price as there was a legally enforceable obligation of the distributor to pay for the product delivered, inventory was reduced by the carrying value of goods shipped, and the net of these amounts, the gross profit, was recorded as deferred income on shipments to distributors on the balance sheet. Under Topic 606, the Company recognizes revenue from sales to distributors upon delivery of the product to the distributor and estimates the amount of the concessions and price protection credits at the point of revenue recognition. Accordingly, the balance of the deferred income on shipments was eliminated as a cumulative effect adjustment of implementing Topic 606 as of January 1, 2018, net of the Company’s estimate of concessions and price protection credits for those contracts.

 

Performance obligations delivered over time –Topic 605 permitted straight-line recognition of revenue for performance obligations that were delivered over time. The new revenue standard requires an entity to recognize revenue based on the pattern of transfer of the services. Entities must use either an input method or an output method to measure progress toward complete satisfaction of a performance obligation. The Company determined that the input method of measuring costs incurred to date compared to total estimated costs to be incurred under the contract most faithfully depicts its performance. Under Topic 606, the Company will record an unbilled receivable (within accounts receivable, net) for the portion of the service that has been completed but not invoiced at the end of each reporting period.

 

Milestone payments – Topic 605 permitted recognition using the milestone method, whereby revenue was recognized upon the completion of substantive milestones once the customers acknowledge the milestones have been met and the collection of the amounts is reasonably assured. The milestone method no longer exists under the new revenue standard. Revenue from milestone payments must be estimated using either the expected value method or the most likely amount method. If it is probable that a significant reversal of cumulative revenue would not occur, the associated milestone value is included in the transaction price. The adoption of Topic 606 did not have an impact on milestone revenue recorded to date as the performance obligations related to such milestones were as of the adoption date.

 

Sales-based royalties – Topic 605 permitted recognition of royalties when reported to the Company, which generally coincided with the receipt of payment. Under the new revenue standard, revenue generated from sales-based royalties from licenses of technology are recognized at the later of when (1) the sale occurs or (2) the performance obligation to which some or all of the sales-based royalty has been allocated is satisfied (in whole or in part).

 

The change in revenue recognition upon adoption of Topic 606 resulted in a decrease in the accumulated deficit balance of $1.3 million on January 1, 2018.

 

The following table summarizes the impact of adopting Topic 606 on select unaudited condensed balance sheet line items (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

 

    

Balances without

 

 

 

 

 

 

the adoption of

March 31, 2018

 

As reported

 

Adjustments

 

Topic 606

Accounts receivable, net

 

$

8,904

 

$

363

 

$

9,267

Inventory

 

 

8,903

 

 

26

 

 

8,929

Total current assets

 

 

53,279

 

 

389

 

 

53,668

Total assets

 

 

57,147

 

 

389

 

 

57,536

Deferred income on shipments to distributors

 

 

 —

 

 

2,197

 

 

2,197

Total current liabilities

 

 

13,688

 

 

2,197

 

 

15,885

Total liabilities

 

 

20,460

 

 

2,197

 

 

22,657

Accumulated deficit

 

 

(117,516)

 

 

(1,808)

 

 

(119,324)

Total liabilities and stockholders’ equity

 

 

57,147

 

 

389

 

 

57,536

 

11


 

Table of Contents

The following table summarizes the impact of adopting Topic 606 on select unaudited condensed statement of operations line items (in thousands, except per share data):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances without

 

 

 

 

 

 

the adoption of

Three Months Ended March 31, 2018

 

As reported

 

Adjustments

 

Topic 606

Product sales

 

$

9,365

 

$

(831)

 

$

8,534

Licensing, royalty, and other revenue

 

 

5,488

 

 

29

 

 

5,517

Total revenue

 

 

14,853

 

 

(802)

 

 

14,051

Cost of sales

 

 

4,898

 

 

(294)

 

 

4,604

Gross profit

 

 

9,955

 

 

(508)

 

 

9,447

Loss from operations

 

 

(1,110)

 

 

(508)

 

 

(1,618)

Net loss and comprehensive loss

 

 

(1,277)

 

 

(508)

 

 

(1,785)

Net loss per common share, basic and diluted

 

 

(0.09)

 

 

(0.03)

 

 

(0.12)

 

The following table summarizes the impact of adopting Topic 606 on select unaudited condensed statement of cash flows line items (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances without

 

 

 

 

 

 

the adoption of

Three Months Ended March 31, 2018

 

As reported

 

Adjustments

 

Topic 606

Cash flows from operating activities

 

 

 

 

 

 

 

 

 

Net loss

 

$

(1,277)

 

$

(508)

 

$

(1,785)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(5,810)

 

 

(28)

 

 

(5,838)

Inventory

 

 

888

 

 

20

 

 

908

Deferred income on shipments to distributors

 

 

(39)

 

 

516

 

 

477

 

ASU No. 2017-09, Compensation-Stock Compensation

 

In May 2017, the FASB issued ASU No. 2017-09, Compensation-Stock Compensation (Topic 718) Scope of Modification Accounting, which is intended to amend the scope of modification accounting for share-based payment arrangements. The amendments in the update provide guidance on types of changes to the terms or conditions of share-based payment awards that would require the Company to apply modification accounting under ASC 718, Compensation-Stock Compensation. This ASU is effective for annual reporting periods beginning after December 15, 2017, and early adoption was permitted. The Company adopted this standard on January 1, 2018, and the impact of its adoption on the Company’s financial statements was not material.

 

ASU No. 2016-15, Statement of Cash Flows

 

In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15 identifies how certain cash receipts and cash payments are presented and classified in the Statement of Cash Flows. The standard is effective for fiscal years and interim periods beginning after December 15, 2017. The standard should be applied retrospectively and early adoption was permitted, including adoption in an interim period. The Company adopted this standard on January 1, 2018, and the impact of its adoption on the Company’s financial statements was not material.

 

 

 

 

 

 

12


 

Table of Contents

3. Revenue

 

Adoption of ASU No. 2014-09

 

On January 1, 2018, the Company adopted ASU No. 2014-09 using the modified retrospective method applied to those contracts which were not completed as of January 1, 2018. Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with Topic 605.

 

The Company sells the majority of its products to its distributors, but does recognize some revenue under licensing and royalty agreements. The following table presents the Company’s revenues disaggregated by sales channel, (in thousands):

 

 

 

 

 

Three Months Ended

 

March 31, 2018

Distributor

$

8,145

Non-distributor

 

6,708

Total revenue

$

14,853

 

All of the Company's performance obligations and associated revenue are generally transferred to customers at a point in time, with the exception of certain revenue streams which are performed over time commensurate with the delivery of service. The following table presents the Company’s revenues disaggregated by timing of recognition (in thousands):

 

 

 

 

Three Months Ended

 

March 31, 2018

Point in time

$

14,472

Over time

 

381

Total revenue

$

14,853

 

The following table presents the Company’s revenues disaggregated by type (in thousands):

 

 

 

 

 

Three Months Ended

 

March 31, 2018

Product sales

$

9,365

License fees

 

5,000

Royalties

 

107

Other revenue

 

381

Total revenue

$

14,853

 

The Company recognizes revenue in three primary geographic regions: North America; Europe, Middle East and Africa (EMEA); and Asia-Pacific and Japan (APJ). The following table presents the Company’s revenues disaggregated by the geographic region to which the product is delivered or licensee is located (in thousands):

 

 

 

 

 

Three Months Ended

 

March 31, 2018

North America

$

1,731

EMEA

 

3,051

APJ

 

10,071

Total revenue

$

14,853

13


 

Table of Contents

 

 

 

4. Balance Sheet Components

 

Inventory

 

Inventory consisted of the following (in thousands):

 

 

 

 

 

 

 

 

 

 

March 31, 

 

December 31, 

 

 

2018

 

2017

Raw materials

 

$

 —

 

$

682

Work-in-process

 

 

4,928

 

 

4,517

Finished goods

 

 

3,975

 

 

4,638

Total inventory

 

$

8,903

 

$

9,837

 

Accrued Liabilities

 

Accrued liabilities consisted of the following (in thousands):

 

 

 

 

 

 

 

 

 

 

March 31, 

 

December 31,

 

    

2018

    

2017

Accrued payroll-related expenses

 

$

1,142

 

$

1,331

Accrued inventory

 

 

183

 

 

524

Deferred rent

 

 

284

 

 

230

Accrued sales commissions payable to sales representatives

 

 

92

 

 

75

Other

 

 

426

 

 

94

Total accrued liabilities

 

$

2,127

 

$

2,254

 

 

 

5. Debt

 

2017 Credit Facility

 

On May 4, 2017, the Company entered into a Loan and Security Agreement with Silicon Valley Bank (2017 Credit Facility) for a $12.0 million term loan. The term loan provides for interest at a floating rate equal to the prime rate minus 0.75%. As of March 31, 2018, the interest rate was 4.00%. The term loan provides for a period of interest-only payments through April 30, 2018, followed by fixed principal and interest payments based on either a 24-month amortization schedule or a 36-month amortization schedule if the Company meets certain sales milestones. As of December 31, 2017, the Company determined it would not meet the sales milestones and as such the term loan will be based on a 24-month amortization schedule. Borrowings under the 2017 Credit Facility mature in May 2020. The Company is required to comply with certain covenants under the 2017 Credit Facility, including requirements to maintain a minimum liquidity ratio, meet certain revenue targets, and restrictions on certain actions without the consent of the lender, such as the disposal and acquisition of its business or property, changes in business, and mergers or acquisitions. An end of term fee of 6% of the amount borrowed must be made when the loan is prepaid or repaid, whether at maturity or as a result of a prepayment or acceleration or otherwise. The additional payment is being accreted using the effective interest method.

 

Security for the 2017 Credit Facility includes all of the Company’s assets except for intellectual property. The 2017 Credit Facility contains customary covenants restricting the Company’s activities, including limitations on its ability to sell assets, engage in mergers and acquisitions, enter into transactions involving related parties, incur indebtedness or grant liens or negative pledges on its assets, make loans or make other investments. Under these covenants, the Company is prohibited from paying cash dividends with respect to its capital stock. The Company was in compliance with all covenants at March 31, 2018. The 2017 Credit Facility contains a material adverse effect clause which provides that an event of default will occur if, among other triggers, an event occurs that could reasonably be expected to result in a material adverse effect on the Company’s business, operations or condition, or on the Company’s ability to perform its obligations under the term loan. As of March 31, 2018, management does not believe that it is probable that the clause will be triggered within the next twelve months, and therefore the term loan is classified as long-term.

 

14


 

Table of Contents

 

The carrying value of the Company’s 2017 Credit Facility at March 31, 2018 was as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

    

Current

    

Long-Term

    

 

 

 

 

Portion

 

Debt

 

Total

Debt, including end of term fee

 

$

5,500

 

$

7,220

 

$

12,720

Less:

 

 

 

 

 

 

 

 

 

Discount attributable to end of term fee and debt issuance costs

 

 

(20)

 

 

(465)

 

 

(485)

Net carrying value of debt

 

$

5,480

 

$

6,755

 

$

12,235

 

The carrying value of the Company’s 2017 Credit Facility at December 31, 2017 was as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

    

Current

    

Long-Term

    

 

 

 

 

Portion

 

Debt

 

Total

Debt, including end of term fee

 

$

4,000

 

$

8,720

 

$

12,720

Less:

 

 

 

 

 

 

 

 

 

Discount attributable to end of term fee and debt issuance costs

 

 

(23)

 

 

(563)

 

 

(586)

Net carrying value of debt

 

$

3,977

 

$

8,157

 

$

12,134

 

Capital Lease Obligations

 

The Company leases certain equipment under a capital lease obligation expiring in October 2020. The balance of the capital lease obligation was $27,000 and $31,000 at March 31, 2018 and December 31, 2017, respectively.

 

Property and equipment under the capital lease amounted to $31,000 at March 31, 2018 and December 31, 2017. Accumulated depreciation and amortization on these assets was $5,000 and $2,000 at March 31, 2018 and December 31, 2017, respectively.

 

 

6. Stockholders’ Equity

 

In February 2018, the Company completed a follow-on underwritten public offering of its common stock under its Registration Statement filed in November 2017 (File No. 333-221331), selling 3,772,447 shares of its common stock at an offering price of $7.00 per share for proceeds of $24.6 million, net of $1.8 million of underwriting discounts and commissions and other offering costs.

 

 

 

15


 

Table of Contents

7. Stock-Based Compensation

 

The following table summarizes the stock option activity for the three months ended March 31, 2018:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding

 

 

 

 

 

 

Weighted-

 

Weighted-

 

 

 

 

 

 

 

 

 

Average

 

Average

 

 

 

 

 

Options

 

 

 

Exercise

 

Remaining

 

Aggregate

 

 

Available for

 

Number of

 

Price Per

 

Contractual

 

Intrinsic

 

    

Grant

    

Options

    

Share

    

Life (years)

    

Value

 

 

 

 

 

 

 

 

 

 

 

(In thousands)

Balance—December 31, 2017

 

83,929

 

1,593,195

 

$

8.88

 

6.6

 

$

1,997

Prior period adjustment

 

(1,026)

 

13,784

 

 

4.54

 

0.3

 

 

 

Options authorized

 

384,516

 

 —

 

 

 

 

 

 

 

 

RSUs granted

 

(36,350)

 

 —

 

 

 

 

 

 

 

 

RSUs cancelled/forfeited

 

400

 

 —

 

 

 

 

 

 

 

 

Options granted

 

(218,600)

 

218,600

 

 

9.12

 

 

 

 

 

Options exercised

 

 —

 

(58,229)

 

 

5.31

 

 

 

$

200

Options cancelled/forfeited

 

 —

 

(391)

 

 

6.63

 

 

 

 

 

Balance—March 31, 2018

 

212,869

 

1,766,959

 

$

7.04

 

7.0

 

$

1,949

Options exercisable—March 31, 2018

 

 

 

783,554

 

$

5.29

 

4.0

 

$

1,803

 

The total grant date fair value of options vested was $377,000 and $107,000 during the three months ended March 31, 2018 and 2017, respectively.

 

The weighted-average grant date fair value of employee options granted during the three months ended March 31, 2018 and 2017 was $4.74 and $3.69 per share, respectively.

 

2016 Employee Stock Purchase Plan

 

In January 2018, there was an increase of 128,172 shares reserved for issuance under the Company’s Employee Stock Purchase Plan (ESPP).

 

Modification of Stock Awards

 

In February 2018, the Company modified the terms of 400,000 vested and unvested stock option awards granted to the Chief Executive Officer, by reducing their exercise price from $16.25 per share to $7.64 per share. There was no change to any of the other terms of the option awards. The modification resulted in an incremental value of $600,000 being allocated to the options, of which $63,000 was recognized to expense immediately based on options that were vested at the time of the modification. The remaining incremental value of $537,000 attributable to unvested options will be recognized over the remaining vesting term through September 2021.

 

16


 

Table of Contents

Restricted Stock Units

 

The following table summarizes Restricted Stock Units (RSUs) activity for the three months ended March 31, 2018:

 

 

 

 

 

 

 

 

 

RSUs Outstanding

 

 

 

 

Weighted-

 

 

 

 

Average

 

 

Number of

 

Grant Date

 

 

Restricted Stock

 

Fair Value Per

 

    

Units

    

Share

Balance—December 31, 2017

 

30,680

 

$

10.55

Granted

 

36,350

 

 

9.12

Cancelled/forfeited

 

(400)

 

 

7.80

Balance—March 31, 2018

 

66,630

 

$

9.79

 

The fair value of RSUs is determined on the date of grant based on the market price of the Company’s common stock on that date. As of March 31, 2018, there was $535,000 of unrecognized stock-based compensation expense related to RSUs to be recognized over a weighted-average period of 3.4 years.

 

Stock-based Compensation Expense

 

The Company recognized stock-based compensation expense from awards granted to employees and non-employees under its equity incentive plans and from its ESPP as follows, excluding amounts related to GLOBALFOUNDRIES, Inc. (GF) (in thousands):

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

March 31, 

 

 

    

2018

    

2017

    

Research and development

 

$

108

 

$

172

 

General and administrative

 

 

433

 

 

226

 

Sales and marketing

 

 

84

 

 

33

 

Total

 

$

625

 

$

431

 

 

As of March 31, 2018, there was $6.2 million of total unrecognized compensation expense related to unvested options which is expected to be recognized over a weighted-average period of 3.3 years.

 

Employee Stock-based Compensation

 

Stock-based compensation expense for employees was $610,000 and $420,000 for the three months ended March 31, 2018 and 2017, respectively.

 

The Company estimated the fair value of each option using the Black-Scholes option-pricing model. The fair value of employee stock options is being amortized on a straight-line basis over the requisite service period of the awards. The fair value of employee stock options was estimated using the assumptions below. Each of these inputs is subjective and its determination generally requires significant judgment.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Option Plan

 

ESPP

 

 

 

 

Three Months Ended

 

Three Months Ended

 

 

 

 

March 31, 

 

March 31, 

 

 

 

    

2018

    

2017

    

2018

    

2017

 

 

Expected volatility

 

51.9-52.0

%  

47.2-47.3

%  

66.2-72.7

%  

 —

%

 

Risk-free interest rate

 

2.70-2.72

%  

2.0-2.1

%  

0.94

%  

 —

%

 

Expected term (in years)

 

6.08

 

5.8-6.0

 

0.5

 

 —

 

 

Dividend yield

 

 —

%  

 —

%  

 —

%  

 —

%

 

 

Non-employee Stock-based Compensation

 

Stock-based compensation expense related to stock options granted to non-employees is recognized as the stock options vest. During the three months ended March 31, 2018, the Company granted 7,200 stock options to non-

17


 

Table of Contents

employees. No stock options were granted to non-employees during the three months March 31, 2017. As of March 31, 2018, options to purchase 45,072 shares of common stock were outstanding with a weighted-average exercise price of $9.15 per share. Stock-based compensation expense for non-employees was $15,000 and $11,000 for the three months ended March 31, 2018 and 2017, respectively.

 

 

8. Related Party Transactions

 

Joint Development Agreement—GLOBALFOUNDRIES

 

On October 17, 2014, the Company entered into a Joint Development Agreement (JDA) with GF, a related party due to its equity ownership in the Company, for the joint development of the Company’s Spin Transfer Torque MRAM (STT-MRAM) technology. The term of the agreement is the later of four years from the effective date or until the completion, termination or expiration of the last statement of work entered into pursuant to the JDA. The JDA also states that the specific terms and conditions for the production and supply of the developed STT-MRAM technology would be pursuant to a separate manufacturing agreement entered into between the parties.

 

Under the JDA, each party licenses its relevant intellectual property to the other party. For certain jointly developed works, the parties have agreed to follow an invention allocation procedure to determine ownership. In addition, GF possesses the exclusive right to manufacture the Company’s discrete and embedded STT-MRAM devices developed pursuant to the agreement until the earlier of three years after the qualification of the MRAM device for a particular technology node or four years after the completion of the relevant statement of work under which the device was developed. For the same exclusivity period associated with the relevant device, GF agreed not to license intellectual property developed in connection with the JDA to named competitors of the Company.

 

Generally, unless otherwise specified in the agreement or a statement of work, the Company and GF share project costs, which do not include personnel or production qualification costs, equally under the JDA. If GF manufactures, sells or transfers to customers wafers containing production quantified STT-MRAM devices that utilize certain design information, GF will be required to pay the Company a royalty. The term of the agreement is four years and is extended until the completion of any development work, if later.

 

As of March 31, 2018 and December 31, 2017, $0 and $25,000 was receivable from GF, respectively. As of March 31, 2018 and December 31, 2017, $2.9 million and $749,000, respectively, were payable to GF for the Company’s share of the project costs under the JDA. The Company incurred project costs, recognized as research and development expense, of $2.1 million and $1.9 million for the three months ended March 31, 2018 and 2017 respectively. The Company entered into a Statement of Work #4B (the SOW 4B) under the JDA with GF effective August 31, 2016. Under SOW 4B, the Company will collaborate with GF in planning, designing and supporting evaluation of 22nm embedded MRAM arrays. The Company was eligible to receive three substantive milestone payments from this collaboration: (a) $569,000 was due upon the delivery of the Company’s database of bias system schematics; (b) $650,000 was due upon the delivery of a Graphic Design Database System package; and (c) $406,000 is due upon demonstration that the embedded MRAM array meets the specifications agreed upon by the two parties. The milestones were achieved during the year ended December 31, 2017. The Company recognized revenue of $0 and $569,000 from GF in the three months ended March 31, 2018 and 2017, respectively.

 

On October 21, 2014, GF participated, along with other investors, in the Company’s Series B redeemable convertible preferred stock financing and purchased 192,307 shares at $26.00 per share. Contemporaneously, the Company sold 461,538 shares of its common stock to GF at a discounted price of $0.00026 per share. The common shares vest upon the achievement of a goal as set forth in the Statement of Work #1 (the SOW) under the JDA. The unvested common shares are subject to repurchase by the Company, if the JDA is terminated for any reason, for a one-year period after such termination, at a price that is the lower of the original price paid by GF or the fair value of the Company’s common stock as of the date of repurchase. The Company has determined that the issuance of these shares of common stock to GF represents compensation for services to be provided under the JDA. Accordingly, the shares are accounted for similar to a stock award granted to a non-employee of the Company and are remeasured to their fair value as they vest. Although the shares issued do not commence vesting until the achievement of the product qualification (the “Initial Measurement Date”), the Company has deemed it probable that the qualification requirement will be met and compensation expense related to the shares issued is being recognized prior to the Initial Measurement Date. Due to the vesting conditions, there will be multiple measurement dates, occurring on the Initial Measurement Date and at the end

18


 

Table of Contents

of each month thereafter. The fair value of vesting shares is effectively fixed at each measurement date while the fair value of the remaining unvested shares will be remeasured each subsequent measurement date until the shares are fully vested. During the year ended December 31, 2016, GF achieved the product qualification as set forth under the SOW. As such, a total of 211,538 shares of common stock became vested on August 21, 2016, the designated Initial Measurement Date. Subsequent to the Initial Measurement Date through March 31, 2018, an additional 182,692 shares of common stock became vested. As of March 31, 2018, there were 67,307 shares unvested that were subject to repurchase.

 

The Company recognized non-cash compensation expense of $237,000 and $255,000 during the three months ended March 31, 2018 and 2017, respectively, in research and development expense related to the vesting of the shares of common stock. The Company recognizes compensation expense based on the estimated fair value of the common stock at each reporting period, which was $7.55 and $7.50 per share as of March 31, 2018 and December 31, 2017, respectively.

 

Transactions with NXP

 

The Company has entered into various transactions with NXP, a related party due to its equity ownership in the Company. The Company leases its manufacturing facility in Chandler, Arizona, from NXP and total rent expense was $327,000 and $289,000 during the three months ended March 31, 2018 and 2017, respectively. NXP also performs processing of the Company’s products in its facility which are capitalized as part of the cost of inventory. The total processing costs incurred by the Company were $864,000 and $427,000 for the three months ended March 31, 2018 and 2017, respectively. In addition, NXP is one of the Company’s largest customers for the sale of backend foundry services, and total revenue from NXP was $482,000 and $572,000 during the three months ended March 31, 2018 and 2017, respectively. In the three months ended March 31, 2018 and 2017, the Company purchased wafers for its Condor product from NXP for $157,000 and $168,000, respectively. There was $652,000 and $638,000 of wafers purchased from NXP for the Company’s Condor product included in inventory as of March 31, 2018 and December 31, 2017, respectively. Amounts due from NXP were $382,000 and $587,000 at March 31, 2018 and December 31, 2017, respectively. Amounts due to NXP were $821,000 and $945,000 at March 31, 2018 and December 31, 2017, respectively.

 

9. Net Loss Per Common Share

 

The following table sets forth the computation of basic and diluted net loss per share (in thousands, except share and per share amounts):

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

March 31, 

 

 

    

2018

    

2017

    

Numerator:

 

 

  

 

 

  

 

Net loss

 

$

(1,277)

 

$

(6,086)

 

Denominator:

 

 

  

 

 

  

 

Weighted-average common shares outstanding

 

 

14,872,369

 

 

12,498,698

 

Less: weighted-average unvested common shares subjected to repurchase

 

 

(83,333)

 

 

(198,717)

 

Weighted-average common shares outstanding used to calculate net loss per common share, basic and diluted

 

 

14,789,036

 

 

12,299,981

 

Net loss per common share, basic and diluted

 

$

(0.09)

 

$

(0.49)

 

 

The following outstanding shares of potentially dilutive securities have been excluded from diluted net loss per common share for the periods presented, because their inclusion would be anti-dilutive:

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

March 31, 

 

 

    

2018

    

2017

 

Options to purchase common stock

 

1,766,959

 

1,481,632

 

Restricted stock units

 

66,630

 

 —

 

Common stock subject to repurchase

 

67,307

 

182,692

 

Common stock warrants

 

27,690

 

27,690

 

Total

 

1,928,586

 

1,692,014

 

 

 

 

19


 

Table of Contents

10. License Agreements

 

In March 2018, the Company entered into a global cross-license agreement with a customer pursuant to which the Company granted a worldwide, non-exclusive, non-transferable, irrevocable, royalty-bearing license under the Company’s patents to use, sell, import and export the Company’s products. Under the cross-license agreement, the Company received a non-refundable license fee and is entitled to quarterly royalty payments based upon low single digits of the average selling price of products covered under the license agreement. The license was transferred to the customer and the Company recognized the non-refundable license fee during the three months ended March 31, 2018. The cross-license agreement will remain in effect until the licensed patents have expired, been abandoned, or ruled invalid.

 

 

 

 

 

20


 

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

You should read the following discussion and analysis of our financial condition and results of operations together with our condensed financial statements and related notes included in Part I, Item 1 of this report and with our audited financial statements and related notes thereto included as part of our Annual Report on Form 10-K for the year ended December 31, 2017.

 

Forward-Looking Statements

 

This discussion contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are identified by words such as “believe,” “will,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “predict,” “could,” “potentially” or the negative of these terms or similar expressions. You should read these statements carefully because they discuss future expectations, contain projections of future results of operations or financial condition, or state other “forward-looking” information. These statements relate to our future plans, strategies, objectives, expectations, intentions and financial performance and the assumptions that underlie these statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements. Factors that might cause such a difference include, but are not limited to, those discussed in this report in Part II, Item 1A — “Risk Factors,” and elsewhere in this report. Forward-looking statements are based on our management’s beliefs and assumptions and on information currently available to our management. These statements, like all statements in this report, speak only as of their date, and we undertake no obligation to update or revise these statements in light of future developments. We caution investors that our business and financial performance are subject to substantial risks and uncertainties.

 

Overview

 

We are the leading provider of MRAM solutions. Our MRAM solutions offer the persistence of non-volatile memory, a type of memory that retains information even in the absence of power, with the speed and endurance of random access memory (RAM). This enables the protection of mission critical data particularly in the event of power interruption or failure. Our MRAM solutions allow our customers in the industrial, automotive, transportation, and enterprise storage markets to design high performance, power efficient and reliable systems without the need for bulky batteries or capacitors.

 

We derive our revenue from the sale of MRAM-based products in discrete unit form, the sale of services, licenses of and royalties on our MRAM and magnetic sensor technology.

 

We work directly with our distributors and customers to have our MRAM devices designed into and qualified for their products. Although we maintain direct sales, support, and development relationships with our customers, once our products are designed into a customer’s product, we sell a majority of our products to those customers through distributors. We generated 55% and 78% for the three months ended March 31, 2018 and 2017, respectively, of our revenue from products sold through distributors.

 

We maintain a direct selling relationship, for strategic purposes, with several key customer accounts. Our sales team and representatives are organized into three primary regions: North America; Europe, Middle East and Africa (EMEA); and Asia-Pacific and Japan (APJ). We recognize revenue by geography based on the region in which our products are sold, and not to where the end products in which they are assembled are shipped. Our revenue by region for the periods indicated was as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31, 

 

 

2018

    

2017

North America

 

$

1,731